Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia

William G. Wierda; John C. Byrd; Susan O'Brien; Steven Coutre; Paul M. Barr; Richard R. Furman; Thomas J. Kipps; Jan A. Burger; Don A. Stevens; Jeff Sharman; Paolo Ghia; Ian W. Flinn; Cathy Zhou; Joi Ninomoto; Danelle F. James; Constantine S. Tam

doi:10.1111/bjh.15791

Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia

William G. Wierda, John C. Byrd, Susan O'Brien, Steven Coutre, Paul M. Barr, Richard R. Furman, Thomas J. Kipps, Jan A. Burger, Don A. Stevens, Jeff Sharman, Paolo Ghia, Ian W. Flinn, Cathy Zhou, Joi Ninomoto, Danelle F. James, Constantine S. Tam

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	184-188
Number of pages	5
Journal	British Journal of Haematology
Volume	186
Issue number	1
DOIs	https://doi.org/10.1111/bjh.15791
Publication status	Published - Jul 2019

Keywords

chronic lymphocytic leukaemia
genomic risk factors
ibrutinib
tumour debulking
tumour lysis syndrome risk

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.15791

Cite this

Wierda, W. G., Byrd, J. C., O'Brien, S., Coutre, S., Barr, P. M., Furman, R. R., Kipps, T. J., Burger, J. A., Stevens, D. A., Sharman, J., Ghia, P., Flinn, I. W., Zhou, C., Ninomoto, J., James, D. F., & Tam, C. S. (2019). Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 186(1), 184-188. https://doi.org/10.1111/bjh.15791

Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia. / Wierda, William G.; Byrd, John C.; O'Brien, Susan; Coutre, Steven; Barr, Paul M.; Furman, Richard R.; Kipps, Thomas J.; Burger, Jan A.; Stevens, Don A.; Sharman, Jeff; Ghia, Paolo; Flinn, Ian W.; Zhou, Cathy; Ninomoto, Joi; James, Danelle F.; Tam, Constantine S.

In: British Journal of Haematology, Vol. 186, No. 1, 07.2019, p. 184-188.

Research output: Contribution to journal › Letter

Wierda, WG, Byrd, JC, O'Brien, S, Coutre, S, Barr, PM, Furman, RR, Kipps, TJ, Burger, JA, Stevens, DA, Sharman, J, Ghia, P, Flinn, IW, Zhou, C, Ninomoto, J, James, DF & Tam, CS 2019, 'Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia', British Journal of Haematology, vol. 186, no. 1, pp. 184-188. https://doi.org/10.1111/bjh.15791

Wierda, William G. ; Byrd, John C. ; O'Brien, Susan ; Coutre, Steven ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Burger, Jan A. ; Stevens, Don A. ; Sharman, Jeff ; Ghia, Paolo ; Flinn, Ian W. ; Zhou, Cathy ; Ninomoto, Joi ; James, Danelle F. ; Tam, Constantine S. / Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia. In: British Journal of Haematology. 2019 ; Vol. 186, No. 1. pp. 184-188.

@article{dc61cd0bd8b14fa0b0497898778c8a62,

title = "Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia",

keywords = "chronic lymphocytic leukaemia, genomic risk factors, ibrutinib, tumour debulking, tumour lysis syndrome risk",

author = "Wierda, {William G.} and Byrd, {John C.} and Susan O'Brien and Steven Coutre and Barr, {Paul M.} and Furman, {Richard R.} and Kipps, {Thomas J.} and Burger, {Jan A.} and Stevens, {Don A.} and Jeff Sharman and Paolo Ghia and Flinn, {Ian W.} and Cathy Zhou and Joi Ninomoto and James, {Danelle F.} and Tam, {Constantine S.}",

year = "2019",

month = jul,

doi = "10.1111/bjh.15791",

language = "English",

volume = "186",

pages = "184--188",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "1",

}

TY - JOUR

T1 - Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia

AU - Wierda, William G.

AU - Byrd, John C.

AU - O'Brien, Susan

AU - Coutre, Steven

AU - Barr, Paul M.

AU - Furman, Richard R.

AU - Kipps, Thomas J.

AU - Burger, Jan A.

AU - Stevens, Don A.

AU - Sharman, Jeff

AU - Ghia, Paolo

AU - Flinn, Ian W.

AU - Zhou, Cathy

AU - Ninomoto, Joi

AU - James, Danelle F.

AU - Tam, Constantine S.

PY - 2019/7

Y1 - 2019/7

KW - chronic lymphocytic leukaemia

KW - genomic risk factors

KW - ibrutinib

KW - tumour debulking

KW - tumour lysis syndrome risk

UR - http://www.scopus.com/inward/record.url?scp=85061447149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061447149&partnerID=8YFLogxK

U2 - 10.1111/bjh.15791

DO - 10.1111/bjh.15791

M3 - Letter

C2 - 30740654

AN - SCOPUS:85061447149

VL - 186

SP - 184

EP - 188

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -